HLA Nov 16, 2020 Somatic Mutations in Lung Cancer Patients With HLA Supertype B44 Influence Immunotherapy Response Nov 2, 2020 Gritstone Oncology Expands Into Phase II Studies With Neoantigen-based Immunotherapy Oct 9, 2020 Eureka Therapeutics Begins Trial Assessing T-cell Therapy in Certain Liver Cancer Patients Apr 1, 2020 OSE Immunotherapeutics Meets Primary Endpoint in Phase III Trial for HLA-A2 Positive Lung Cancer Feb 19, 2020 Study Finds Potential Biomarkers for Checkpoint Inhibitor Response in Melanoma Breaking News Marengo Therapeutics Begins Phase I/II Trial of Selective T-Cell-Targeted Antibody Janssen, Legend Biotech's Carvykti Bests Chemo in Earlier-Line Multiple Myeloma Trial In Brief This Week: PreludeDx, Johnson & Johnson, Syros, Magenta, Merck NICE Backs Gilead Sciences' Yescarta as Third-Line Option for Lymphoma Patients BMS Eyeing Breyanzi Indications in CLL, SLL After Positive Trial Data Enhertu Approved in Europe for HER2-Low Metastatic Breast Cancer
